Physician

James H Auerbach, MD

According to 2025 Medicare claims, James Auerbach, MD (NPI: 1154426427) practices dermatology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF NEW MEXICO, LLC (NPI: 1447615760; TIN: 47-5389158) and primary practice location at 87505-4762.

Auerbach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,269 traditional Medicare patients, billed 10,415 HCPCS/CPT codes, and received $350,065 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,123 prescription claims across 399 beneficiaries totaling $372,195 in drug costs, led by Humira Pen (Adalimumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $137,368 to $372,195. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$232K$465K2015 Medicare payment: $361,023 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $394,366 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $423,355 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $464,543 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $439,184 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $291,780 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $344,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $330,812 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $341,751 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $350,065 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,41210,779$361,023
20161,57111,329$394,366
20171,55112,001$423,355
20181,56112,763$464,543
20191,47811,351$439,184
20201,1278,545$291,780
20211,29310,850$344,986
20221,25310,060$330,812
20231,31410,436$341,751
20241,26910,415$350,065

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$186K$372K2015 Drug cost: $137,368 (USD; Tot_Drug_Cst)2016 Drug cost: $153,980 (USD; Tot_Drug_Cst)2017 Drug cost: $166,183 (USD; Tot_Drug_Cst)2018 Drug cost: $156,507 (USD; Tot_Drug_Cst)2019 Drug cost: $165,844 (USD; Tot_Drug_Cst)2020 Drug cost: $125,198 (USD; Tot_Drug_Cst)2021 Drug cost: $116,747 (USD; Tot_Drug_Cst)2022 Drug cost: $140,716 (USD; Tot_Drug_Cst)2023 Drug cost: $162,884 (USD; Tot_Drug_Cst)2024 Drug cost: $372,195 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154151,080$137,368
20164221,118$153,980
20174581,073$166,183
20184611,192$156,507
20193961,110$165,844
20203641,055$125,198
20213821,101$116,747
2022380962$140,716
2023355953$162,884
20243991,123$372,195

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths7621,134$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0211,537$58
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more342460$36
17000Destruction of precancer skin growth, 1 growth7821,263$31
17003Destruction of precancer skin growth, 2-14 growths6364,665$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab11308$73,560
Dupixent PenDupilumab18462$62,906
TretinoinTretinoin592,137$5,435
KetoconazoleKetoconazole2849,482$5,201
Doxycycline HyclateDoxycycline Hyclate1157,881$4,056

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for James H. Auerbach, MD?

Tedicare shows public-source Medicare data for James H. Auerbach, MD (NPI 1154426427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James H. Auerbach, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James H. Auerbach, MD?

James H. Auerbach, MD is linked to EPIPHANY DERMATOLOGY OF NEW MEXICO, LLC (billing NPI 1447615760) in the available physician profile data.

Does James H. Auerbach, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.